February 24, 2023 07:05 AM EST
People

Ob­sE­va makes cuts to lead­er­ship team, board of di­rec­tors in an­oth­er at­tempt to stay afloat

Katherine Lewin

News Reporter

Women’s health biotech Ob­sE­va is down­siz­ing its US-based ex­ec­u­tive team and board of di­rec­tors, the com­pa­ny an­nounced Fri­day, the lat­est in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: Two Vi­da Ven­tures co-founders ex­it the VC firm

Cas­es of se­vere RSV in two Mod­er­na vac­cine can­di­dates' tri­als raise ques­tions about fu­ture

Ear­ly da­ta on BTK de­graders sug­gest promise of next-gen ap­proach

J&J, Leg­end’s Carvyk­ti clears a type of blood can­cer in ‘nine out of 10’ pa­tients

'It's the bi­ol­o­gy, stu­pid': Re­la­tion and GSK team up on fi­bro­sis, os­teoarthri­tis

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times